Community
Turkey’s Erdogan tells Ukraine’s Zelenskiy that Black Sea attacks are inexplicable
By Marcus Chen
KFGO
China’s InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
Katherine Langford
Editor-in-Chief · Thursday, September 24, 2026 at 4:21 AM · 1 min read
Sept 24 (Reuters) Chinese drugmaker InnoCare Pharma said on Thursday it entered into a research collaboration and license agreement with Eli Lilly that could be worth up to about $3.35 billion. (Reporting by Aamir Shaik Khalid in Bengaluru; Editing by Subhranshu Sahu)
Advertisement
More Community stories
Community
Japan’s Katayama says principles of Japan-US FX intervention remain in place
By Katherine Langford
KFGO
Community
Taiwan upgrades maritime patrol capacity for vulnerable South China Sea outpost
By Katherine Langford
KFGO
Community
Australia’s unemployment rate hits five-year high in August as more seek work
By Marcus Chen
KFGO